Thioxo quinoline compounds, composition and method of use
AssigneesICI Pharma, Imperial Chemical Industries PLC
InventorPierre A. R. Bruneau
Life of this patent
Estimating the term…
Loading patent…
AssigneesICI Pharma, Imperial Chemical Industries PLC
InventorPierre A. R. Bruneau
Estimating the term…
The invention concerns a thioxo heterocycle of the formula I ##STR1## wherein Q is a 10-membered bicyclic heterocyclic moiety containing 1 or 2 N's which bears 1 or 2 thioxo substituents and which is optionally further substituted; A.sup.1 is a direct link to X.sup.1 or (1-3C)alkylene; X.sup.1 is oxy, thio, sulphinyl, sulphonyl or imino; Ar is optionally substituted phenylene or pyridylene; R.sup.1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- which, together with the carbon atom to which A.sup.2 and A.sup.3 are attached, defines a ring having 5 to 7 ring atoms, wherein each of A.sup.2 and A.sup.3 is (1-3C)alkylene and X.sup.2 is oxy, thio, sulphinyl or sulphonyl; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
A thioxo heterocycle of the formula I
A pharmaceutical composition which comprises a thioxo heterocycle of the formula I, or a pharmaceutically-acceptable salt thereof, as claimed in any one of claims 1-7 and 11 in association with a pharmaceutically-acceptable diluent or carrier.
Dependencies are inferred from the claim text.